Included and excluded studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Characteristics of included studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Extraction data table. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

<i>Kif3a</i> controls renal branching morphogenesis in a GLI3R-dependent manner. by Lijun Chi (196000)

“…(T) Quantitation of NCAM-positive structures in N, O and P reveals a significant decrease in <i>Kif3a^−/−UB</i> mice compared to WT and <i>Kif3a^−/−UB</i>;<i>Gli3^Δ699/+</i> mice. (*, P<0.05, **, P<0.01, *** P<0.001). …”

The effects of glucose on <i>K</i>. <i>pneumoniae</i> STU1. by Yu-Tze Horng (2043019)

Impingement area at the anteroinferior femoral neck in relation to different femoral versions and degrees of hip flexion. by Jonathan Bourget-Murray (10884942)

Cyclic fatigue test block. by Beliz Özel (16475132)

Angpt1 deficiency increased vascular rarefaction after UUO. by Krishnapriya Loganathan (4729575)

“…Data shown as mean ± SEM. Scale bar, 50 μm. ## p<0.01, ### p<0.001 comparing to WT CL3.5h. …”

Data_Sheet_1_Invasion of a Legume Ecosystem Engineer in a Cold Biome Alters Plant Biodiversity.pdf by Vanessa M. S. Vetter (5339033)

“…L. nootkatensis was introduced to Iceland in the 1940s to address erosion problems and foster reforestation, but subsequently became a high-latitude invader. In a local field survey, we quantified the impact of L. nootkatensis invasion at three different cover levels (0, 10–50, and 51–100%) upon native plant diversity, richness, and community composition of heath-, wood-, and grasslands using a pairwise comparison design and comparisons of means. …”

Qualitative multiple condition image retrieval results. by Donghwan Lee (11288139)

Response of a Habitat-Forming Marine Plant to a Simulated Warming Event Is Delayed, Genotype Specific, and Varies with Phenology by Laura K. Reynolds (318282)

“…However, after returning temperature to ambient levels, we found strongly negative, delayed effects of warming on production: shoot production declined by 27% and total biomass decreased by 50% relative to individuals that had not been warmed. …”

GFP localization and expression in wild-type and <i>tbc-2</i> mutants. by İçten Meraş (13184380)

Binding of nucleotide and compound 1 to yeast F₁ α- and β-subunits. by Lindsay B. Tulloch (1266861)

Context and impact of elevated antisense expression levels in the Δ<i>rho</i> mutant. by Ulrike Mäder (205299)

“…Each annotated gene is represented by a point. There is a strong negative correlation between sense and antisense expression in the Δ<i>rho</i> mutant (Pearson correlation coefficient r = -0.73) that is also visible but much weaker in the wild-type (r = -0.30). …”

Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes by Pavel Štarha (490367)

“…Complexes showed high <i>in vitro</i> cytotoxicity against nine human cancer cell lines (IC₅₀ ranging from 0.4 to 12.8 μM), including the <i>cisplatin</i>-resistant ovarian cancer cell line (A2780R; IC₅₀ = 1.0–3.5 μM). …”

B-THP-Ts bind to C-terminal GFP-PTP tagged F₁ α- and β- subunits. by Lindsay B. Tulloch (1266861)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)